Acsiapharma - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | - | - | - | - | - | - | - | - |
| Profit before tax | - | - | - | - | - | - | - | - |
| Net profit | -412 | -2,359 | -460 | -9,523 | -13,053 | -586 | -611 | -626 |
| Equity | 1,024 | -1,335 | -1,794 | -11,317 | -24,370 | -24,956 | -25,567 | -26,193 |
| Liabilities | 0 | 1,366 | 2,050 | 17,300 | 28,068 | 28,300 | 28,800 | 29,400 |
| Non-current assets | 0 | 0 | 0 | 3,523 | 2,986 | 2,986 | 2,986 | 2,986 |
| Current assets | 1,024 | 31 | 256 | 2,389 | 621 | 245 | 122 | 91 |
| Total assets | 1,024 | 31 | 256 | 5,912 | 3,607 | 3,231 | 3,108 | 3,077 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 62 | 62 | 62 |
|
Financial indicators
|
||||||||
| Revenue change y/y | - | - | - | - | - | - | - | - |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -40.2% | -7609.7% | -179.7% | -161.1% | -361.9% | -18.1% | -19.7% | -20.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -40.2% | - | - | - | - | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | - | - | - | - | - | - | - |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | - | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Acsiapharma - Social security debts
The company had no debts to Sodra
Acsiapharma - VMI tax arrears
As of 2026-09-02, the amount of overdue STI tax debt of the company Acsiapharma is: 0 €
| From | To | Overdue, € |
|---|---|---|
| 2026-01-11 | 2026-09-02 | 0.1 |
| 2025-01-14 | 2025-12-23 | 0.1 |
| 2024-01-09 | 2024-12-20 | 0.1 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.